Evidence map›Paper›PMID 16227253›Full record

ArticleJournal of virology2005

Evolution of hepatitis delta virus RNA genome following long-term replication in cell culture.

Jinhong Chang, Severin O Gudima, John M Taylor

Abstract read
In one paragraph

Article in Journal of virology, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Human hepatitis D virus-specific T cell epitopes.JHEP reports : innovation in hepatology · 2021
    Review
  2. Hepatitis D Virus Replication.Cold Spring Harbor perspectives in medicine · 2015
    Review
  3. Control of ADAR1 editing of hepatitis delta virus RNAs.Current topics in microbiology and immunology · 2012
    Review
  4. Article
  5. Origin of hepatitis delta virus.Future microbiology · 2010
    Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jinhong ChangFox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, Pennsylvania 19111-2497. JM_Taylor@FCCC.edu.
Severin O Gudima
John M Taylor

Funding

WORD PROCESSING CENTER--COREP30CA006927 · NCI · RESEARCH INST OF FOX CHASE CAN CTR · PI Margaret von Mehren · 1985 to 2026
$138.8M
STRUCTURE AND REPLICATION OF HEPATITIS DELTA VIRUSR01AI026522 · NIAID · RESEARCH INST OF FOX CHASE CAN CTR · PI TAYLOR, JOHN MARSTON · 1988 to 2009
$5.1M
NCI NIH HHS CA06927NCI NIH HHS P30 CA006927NIAID NIH HHS AI-26522NIAID NIH HHS R01 AI026522
6 · The paper itself

Abstract

Previous studies have defined a novel cell culture system in which a modified RNA genome of hepatitis delta virus (HDV) is able to maintain a low level of continuous replication for at least 1 year, using a separate and limited DNA-directed source of mRNA for the essential small delta protein. This mode of replication is analogous to that used by plant viroids. An examination was made of the nucleotide changes that accumulated on the HDV RNA during 1 year of replication. The length of the RNA genome was maintained, except for some single-nucleotide deletions and insertions. There was an abundance of single-nucleotide substitutions, with a 22-fold excess of these being base transitions rather than transversions. Of the detected transitions, at least 70% were consistent with being the consequences of posttranscriptional RNA editing by an adenosine deaminase acting on RNA. The remainder of the changes, including the single-nucleotide insertions and deletions, are likely to be the consequence of misincorporation during transcription. In addition, an intermolecular competition assay was used to show that the majority of the genomes present after 1 year of replication were essentially as competent in replication as the original single HDV RNA sequence that was used to initiate the genome replication. A model is provided to explain how, in this experimental system, the observed single-nucleotide changes were essentially neutral in terms of their effect on the ability of the HDV genome to carry out continued rounds of replication.

Indexed as

Base SequenceCell LineEvolution, MolecularHepatitis Delta VirusHumansMolecular Sequence DataRNA, ViralSequence AlignmentTime FactorsVirus ReplicationRNA, Viral

Identifiers

PMID16227253
PMCPMC1262577

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.